Get all your news in one place.
100's of premium titles.
One app.
Start reading
The Conversation
The Conversation
Paula Lorgelly, Professor of Health Economics, University of Auckland, Waipapa Taumata Rau

A funding boost for NZ’s drug-buying agency Pharmac to pay for cancer drugs is welcome – but it won’t solve underlying issues

Hagen Hopkins/Getty Images

This week the coalition government made a significant investment in Pharmac, increasing funding by NZ$604 million over the next four years.

In doing so, it delivered on a National Party election promise to fund 13 cancer drugs. Specifically, it will fund seven of those named during the election, while the remaining six will be replaced with “as good as or better alternatives”. In total, this will fund up to 54 new drugs, including 26 cancer drugs.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.